Notable Analyst Rating Changes 09/06: (AKS) (ATVI) (GOLD) Upgraded; (NOK) (CLF) (OCZ) Downgraded
Tweet Send to a Friend
Get Alerts AKS Hot Sheet
Trade AKS Now!
UPGRADES
Longbow Research lifts AK Steel (NYSE: AKS) from Neutral to Buy.
Piper Jaffray boosts Activision Blizzard (Nasdaq: ATVI) from Neutral to Overweight, moving its price target from $13 to $14.
JPMorgan upgrades Randgold Resources Ltd. (Nasdaq: GOLD) from Neutral to Overweight.
Janney Montgomery Scott raises Wright Express (NYSE: WXS) from Neutral to Buy, while moving its price target from $61 up to $75.
For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades
DOWNGRADES
Nokia (NYSE: NOK) downgraded by two today:
NEW COVERAGE
Credit Suisse initiates Arena Pharma (Nasdaq: ARNA) with a Underperform and $6 target.
Topeka Capital assumes Monsanto (NYSE: MON) at Hold and price target of $83.
Maxim Group starts ImmunoCellular Therapeutics (NYSE: IMUC) at Buy and $18 target.
Rigel Pharmaceuticals (Nasdaq: RIGL) started by two today:
Visit our new Ratings Insider portal to get the most comprehensive and up-to-date analyst coverage on the Street.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Longbow Research lifts AK Steel (NYSE: AKS) from Neutral to Buy.
Piper Jaffray boosts Activision Blizzard (Nasdaq: ATVI) from Neutral to Overweight, moving its price target from $13 to $14.
JPMorgan upgrades Randgold Resources Ltd. (Nasdaq: GOLD) from Neutral to Overweight.
Janney Montgomery Scott raises Wright Express (NYSE: WXS) from Neutral to Buy, while moving its price target from $61 up to $75.
For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades
DOWNGRADES
Nokia (NYSE: NOK) downgraded by two today:
- Societe Generale from Sell to Hold; and
- Deutsche Bank from Hold to Sell, while dropping its price target from €1.70 to €1.60. Click Here for more color.
- Longbow Research from Buy to Neutral; and
- UBS from Buy to Neutral.
- Needham & Company from Buy to Hold. Click Here for more color;
- Craig-Hallum from Buy to Hold, moving its price target from $4.50 to $5; and
- FBN Securities from Sector Perform to Underperform.
- Raymond James from Strong Buy to Market Perform; and
- Stifel Nicolaus from Buy to Hold.
NEW COVERAGE
Credit Suisse initiates Arena Pharma (Nasdaq: ARNA) with a Underperform and $6 target.
Topeka Capital assumes Monsanto (NYSE: MON) at Hold and price target of $83.
Maxim Group starts ImmunoCellular Therapeutics (NYSE: IMUC) at Buy and $18 target.
Rigel Pharmaceuticals (Nasdaq: RIGL) started by two today:
- Leerink Swann at Outperform and price target of $16. Click Here for more color; and
- Roth Capital at Buy and $15 target.
Visit our new Ratings Insider portal to get the most comprehensive and up-to-date analyst coverage on the Street.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- J.P. Morgan (JPM) CEO Dimon Might Have Enough Votes to Stay Chairman - NY Times
- Streetinsider.com's Hot Lunchtime Reads 05/15: (HBC) (TSLA) (WTR) (BMY)
- StreetInsider.com Pre-Open Movers 5/15: (MFLR) (CHCI) (SPWR) Higher; (XONE) (DE) (P) Lower (more...)
Create E-mail Alert Related Categories
Special ReportsRelated Entities
Credit Suisse, Piper Jaffray, Stifel Nicolaus, Deutsche Bank, UBS, JPMorgan, Raymond James, Needham & Company, Roth Capital, Janney Montgomery Scott, Longbow Research, Maxim Group, Notable Analyst Rating ChangesLogin with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!

Up)